This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MCU | Ann: Removal from Official List | 24/11/10 | 0 | 290 | |||
|
|||||||
DBA +MCU | Ann: Ceasing to be a substantial holder from DBA | 19/11/10 | 0 | 270 | |||
|
|||||||
MCU | Ann: Final Director's Interest Notice x7 | 17/11/10 | 0 | 270 | |||
|
|||||||
MCU | Ann: Implementation of Scheme of Arrangement | 17/11/10 | 0 | 385 | |||
|
|||||||
MCU | Ann: Restatement of Scheme Consideration Election | 12/11/10 | 0 | 305 | |||
|
|||||||
MCU | Ann: Results of Scheme Consideration Elections | 11/11/10 | 0 | 183 | |||
|
|||||||
MCU | Ann: Appendix 3B | 04/11/10 | 0 | 199 | |||
|
|||||||
MCU | Ann: Update - Scheme of Arrangement with Aegis | 17:08 | 0 | 178 | |||
|
See All Discussions